Kara N. Maxwell, MD, PhD, discusses the need to improve genetic testing rates for BRCA mutations in the male population.
Back
Review Sheds Light on Genetic Testing in Patients With Metastatic Prostate Cancer
Kara N. Maxwell, MD, PhD, discusses data from a review published in JAMA Oncology which found that despite BRCA mutations being known actionable alterations, genetic testing rates for these aberrations are significantly lower in males compared with females.
Review Sheds Light on Genetic Testing in Patients With Metastatic Prostate Cancer
Episodes
All
All
Kara N. Maxwell, MD, PhD, discusses the risk of cancer for males carrying BRCA mutations.
Kara N. Maxwell, MD, PhD, discusses the prevalence of germline mutations in racially diverse cohorts of patients with metastatic prostate cancer.
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Breast Cancer Buzz at ASCO 2026: De-Escalation Strategies, Targeted Therapies, and More
3
Teclistamab Plus Talquetamab Yields Significant Survival Benefits in Earlier-Line R/R Myeloma
4
Dr Cummings on the Utility of Adjuvant Immunotherapy Alone in Early-Stage NSCLC
5